Huron Consulting Group (HURN) to Release Earnings on Tuesday

Huron Consulting Group (NASDAQ:HURN) is expected to be issuing its Q1 2025 quarterly earnings data after the market closes on Tuesday, April 29th. Analysts expect the company to announce earnings of $1.16 per share and revenue of $389.27 million for the quarter. Huron Consulting Group has set its FY 2025 guidance at 6.800-7.600 EPS.

Huron Consulting Group (NASDAQ:HURN) last issued its earnings results on Tuesday, February 25th. The business services provider reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.38. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The business had revenue of $399.31 million during the quarter, compared to analysts’ expectations of $380.62 million. On average, analysts expect Huron Consulting Group to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Huron Consulting Group Stock Performance

NASDAQ HURN opened at $138.13 on Tuesday. The company has a fifty day moving average of $141.42 and a two-hundred day moving average of $128.02. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. Huron Consulting Group has a 1 year low of $84.26 and a 1 year high of $153.85. The company has a market capitalization of $2.48 billion, a PE ratio of 30.03 and a beta of 0.37.

Insider Transactions at Huron Consulting Group

In other news, Director H Eugene Lockhart sold 1,042 shares of the stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $125.15, for a total transaction of $130,406.30. Following the completion of the transaction, the director now directly owns 24,672 shares of the company’s stock, valued at approximately $3,087,700.80. This represents a 4.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director John Mccartney sold 500 shares of Huron Consulting Group stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $142.67, for a total value of $71,335.00. Following the completion of the sale, the director now owns 52,121 shares in the company, valued at approximately $7,436,103.07. This trade represents a 0.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 78,781 shares of company stock worth $11,484,452. Company insiders own 2.15% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on HURN. Barrington Research restated an “outperform” rating and set a $167.00 price target on shares of Huron Consulting Group in a research note on Thursday, March 27th. Benchmark restated a “buy” rating and set a $165.00 target price on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Wedbush upped their price target on shares of Huron Consulting Group from $150.00 to $165.00 and gave the company an “outperform” rating in a research report on Wednesday, March 26th. William Blair reissued an “outperform” rating on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Finally, Truist Financial upped their target price on shares of Huron Consulting Group from $165.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday, March 4th. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $169.25.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.